DailyDoctor Archive Specialties Get app
Back to the 4 November 2026 edition

Research · 02 of 04

Crocin from saffron lowered depression and anxiety scores in small, inconsistent trials

Crocin may modestly lower depression and anxiety scores, but the evidence is too inconsistent to recommend it over standard treatment.

Design
Dose-response meta-analysis of randomised trials
Population
14 RCTs of crocin supplementation, mostly from one country
Primary outcome
Change in depressive and anxiety symptom scores per 30 mg/day
Effect
Depression −3.37 (−4.80 to −1.94); anxiety −2.73; I² about 97%

This dose-response meta-analysis pooled 14 randomised trials of crocin, the main carotenoid in saffron, for depressive and anxiety symptoms. Most were small and conducted largely in one country.

Each 30 mg/day increase in crocin was associated with a 3.37-point fall in depressive symptom scores (95% CI −4.80 to −1.94) and a 2.73-point fall in anxiety scores, with roughly linear dose-response curves. Heterogeneity was extreme, with I² about 97% for both outcomes.

Patients in India often ask about saffron and other herbal products. This review offers a reason to keep crocin on the research agenda, not a reason to recommend it in place of established treatment. Product strength and purity also vary widely outside trials.

  • Ask patients directly about herbal and supplement use, including saffron products
  • Do not substitute crocin for an antidepressant or psychological therapy on this evidence
  • Check for interactions and bleeding risk when supplements are combined with prescribed drugs
  • Note that commercial saffron products vary in crocin content

Why it matters

Gives a straight answer when a patient asks whether saffron supplements work for mood.

Don't overread it

Extreme heterogeneity and small single-country trials mean the pooled effect is unreliable.

The statistics, in plain English

An I² of 97% means almost all of the variation between trials reflects real differences in the studies, not chance, so a single pooled number describes them poorly. Small trials from one region are also prone to publication bias, which tends to inflate pooled effects.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

depressionanxietysuicide

Tomorrow morning, before your first patient

One edition a day for psychiatry, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app